Combined talimogene laherparepvec and binimetinib in NRAS-mutated melanoma induces antitumor immunity
Journal of Clinical Investigation · 16.11.2026 · 136 (22)
DOI: 10.1172/jci211137 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, erschienen am 16.11.2026. Verfasst von Tony Yao und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine. Hauptthemen laut MEDLINE: Melanoma, GTP Phosphohydrolases, Membrane Proteins, Skin Neoplasms. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, National Cancer Institute.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine.
- Division of Dermatology.
- Department of Neurology.
- Division of Oncology, and.
- Department of Pathology and Immunology, Washington University, St. Louis, Missouri, USA.
Förderung
- NCI NIH HHS
- National Cancer Institute
Zitieren
APA
Yao, T., Chen, R. E., Yamada, M., Moore, J. R., Jimenez, M., Huang, T., Cornelius, L., Ansstas, G., Saligrama, N., & Chen, D. Y. (2026). Combined talimogene laherparepvec and binimetinib in NRAS-mutated melanoma induces anti-tumor immunity. Journal of Clinical Investigation. https://doi.org/10.1172/jci211137
Vancouver
Yao T, Chen RE, Yamada M, Moore JR, Jimenez M, Huang T, et al. Combined talimogene laherparepvec and binimetinib in NRAS-mutated melanoma induces anti-tumor immunity. Journal of Clinical Investigation. 2026. doi:10.1172/jci211137
BibTeX
@article{Yao2026,
author = {Yao, Tony and Chen, Rita E and Yamada, Melissa and Moore, J Russell and Jimenez, Marissa and Huang, Tammy and Cornelius, Lynn and Ansstas, George and Saligrama, Naresha and Chen, David Y},
title = {Combined talimogene laherparepvec and binimetinib in NRAS-mutated melanoma induces anti-tumor immunity},
journal = {Journal of Clinical Investigation},
year = {2026},
doi = {10.1172/jci211137}
}
EUVIMED